Michi M. Shinohara, MDDr. Shinohara is a dermatologist and dermatopathologist who specializes in treating skin cancer, especially cutaneous T cell lymphoma.
Patient Care Philosophy:I believe in providing the most up to date and relevant information available to patients to engage them in their medical care, and use evidence based treatments whenever possible. I strive to be compassionate and accessible to my patients, treating them as I expect my friends and family to be treated.
Dr. Shinohara's Resume
- Clinical Assistant Professor, University of Washington School of Medicine
- Cutaneous T Cell Lymphoma
- Cutaneous B Cell Lymphoma
- Complex medical dermatology
- Skin complications from cancer therapy
ExperiencePreviously trained in internal medicine at University of Washington School of Medicine; On staff 2009-2010 and 2011-present.
Education And Training
- Internal Medicine, University of Washington (2002-05)
- Dermatology, University of Washington (2006-09, Chief Resident 2008-09)
- Dermatopathology, University of Pennsylvania (2010-2011)
More InformationClick here for more information on Dr. Shinohara.
Dr. Shinohara's Story
Michi Shinohara, MD believes in providing the most up to date and relevant information available to patients to engage them in their medical care, and use evidence-based treatments whenever possible.
“I strive to be compassionate and accessible to my patients, treating them as I expect my friends and family to be treated,” she says.
Shinohara initially studied to be a scientist, but found that she missed the human interactions she envisioned medicine would have. “I chose to be a doctor to help patients treat or manage their diseases so that they can enjoy their lives as fully as they want to.”
During her internal medicine training, she chose to become a dermatologist because, she says, “dermatologists have the unique opportunity to help patients with often very visible diseases.” Once a dermatologist though, she became fascinated by the breadth of appearances and behavior of skin malignancies, particularly cutaneous T cell lymphoma (CTCL). “There is an enormous amount of misinformation and misconception regarding CTCL, and I feel I can really have an impact both in patient’s understanding of their condition and in their treatment,” she says.
Shinohara is establishing a registry for patients with cutaneous lymphoma at the University of Washington/SCCA, and preparing to participate in clinical trials for patients with advanced CTCL. CTCL is a rare disease, and collecting information on the course of our patients and engaging in clinical research is vital to forwarding our understanding and treatment of these skin conditions.
“I hope to see the development of useful cancer biomarkers for CTCL in the future,” Shinohara says, “to aid in diagnosis, as this condition is often difficult to diagnose and often diagnosed after substantial delay. There are more and more novel therapeutics for CTCL being introduced, and I hope that this continues, and that we understand better how to optimally use these therapies in conjunction with existing treatments.”
Outside of work, Shinohara is an avid eater, and enjoys cooking and trying new foods. “Thankfully for my waistline, I also enjoy running and am passionate about Crossfit,” she says. After work, she looks forward to spending time with her family including two psychotic cats.